Pharmacoepidemiology and Drug Safety · 2004 · 84 citations · 21 references
Our definitions of cumulative and continuous polypharmacy serve to set upper and lower bounds for the estimate of polypharmacy. Our method for simultaneous polypharmacy gives numbers that diverge in some respects, but it is better at showing transient changes in medications. The methods are complementary and allow exploration of various aspects of medication use, such as cumulative medication exposure over time, the influence of chronic medical problems, and the causes of rapid changes in medications.
21
Persistence of Use of Lipid-Lowering Medications
Jerry Avorn, Johanne Monette, Anne Sophie Lacour et al. · JAMA · 1998 · 639 citations
New Jersey, Lipid-lowering Drugs, Cardiovascular Disease +14
Validation of pharmacy records in drug exposure assessment
Hong S. Lau, Anthonius de Boer, K. S. Beuning et al. · Journal of Clinical Epidemiology · 1997 · 376 citations
Polypharmacy: correlations with sex, age and drug regimen
Lars Bjerrum, Jes Søgaard, Jesper Hallas et al. · European Journal of Clinical Pharmacology · 1998 · 238 citations